Other frequently reported side effects associated with semaglutide may include headache, abdominal pain, nasopharyngitis, dizziness, gastroenteritis, constipation, and GERD.[2] Semaglutide has a boxed warning, or a serious safety warning by the FDA, for the risk of thyroid C-cell tumors.[2] Additional safety warnings and precautions are acute pancreatitis, gall bladder disease, kidney injury, increased heart rate, and hypersensitivity reactions
To assess your hydration status objectively, observe your urine color throughout the day
These injectable medications help regulate appetite, improve blood sugar control, and support sustainable weight reduction for people struggling with obesity or metabolic disorders
However, our findings challenge this notion, instead revealing potential limitations that must be addressed to advance more effective therapies
In the Surmount-OSA clinical trial, patients lost an average of 15% of their body weight using tirzepatide, which led to approximately 50% improvement in sleep apnea severity
For people with type 2 diabetes, tirzepatide has demonstrated superior A1C reduction compared to GLP-1-only medications